Exercise and Genotype in Sub-acute Stroke
Stroke

About this trial
This is an interventional treatment trial for Stroke focused on measuring Stroke, Rehabilitation, Neurosciences, Exercise, Neuroplasticity, BDNF, Cardiovascular training, Motor function, HIIT, Genotype
Eligibility Criteria
Inclusion Criteria:
- Individuals 40-80 years old
- Who had a first-ever ischemic (cortical or subcortical) stroke confirmed by MRI/CT
- Who had stroke 2 to 6 weeks prior to participation
- With recordable motor-evoked potentials (MEPs) elicited with transcranial magnetic stimulation (TMS) from the affected hemisphere
- With no serious musculoskeletal or neurological conditions other than stroke
- With sufficient cognitive/communicative capacity to safely perform the protocols.
Exclusion Criteria:
- Hemorrhagic stroke
- Cognitive impairment/dysphasia affecting informed consent
- Concurrently enrolled in another exercise program
- Major psychiatric or previous neurological disease
- Absolute contraindications to TMS or exercise
Sites / Locations
- Jewish Rehabiliation Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Cardiovascular training
Standard Therapy
Cardiovascular training will comprise 4 weeks of moderate-to-vigorous continuous training followed by 4 weeks of progressive high-intensity interval training (HIIT) performed on recumbent steppers. This intervention will be performed in addition to the conventional standard therapy sessions. We will start with very moderate intensities and prepare participants for higher intensities. Introducing HIIT will allow us to use higher intensities over short bursts of exercise interspersed with periods of active rest. HIIT is more effective than continuous training to increase BDNF and we have shown that even a single bout of HIIT reduces interhemispheric imbalances in excitability and improves motor learning in chronic stroke.
Will comprise 8 weeks of the control protocol that includes regular sessions of physiotherapy, occupational therapy, and speech therapy.